The Common Wealth Fund has recently released a healthcare performance comparison report between 11 c...
Read moreThe unprecedented growth of the Digital Therapeutic Market (DTx) has been one of the key highlights ...
Read moreICER recently outlined its plans to annually assess Barriers to Fair Access within prescription drug...
Read moreFollowing our first company wide sustainability meeting we’re very excited to be embarking on our ...
Read moreWith many anticipated new medicines for rare diseases, countries are beginning to prepare appropriat...
Read moreNHS England, the UK’s publicly funded healthcare system, will be introducing a £340m fund dedicat...
Read moreAduhelm is the first drug to be approved by the FDA that claims to treat Alzheimer's disease rather ...
Read moreWe’ve prepared a summary of our key market access blogs and news articles from the second quarter ...
Read moreThe EU is known for the variety of market access rules its member states impose. We’re here to gui...
Read moreA dive into the complex and expensive world of gene therapy pricing and access.
Read more